+254745601747

info@clinicalmedhub.com

Nairobi, Kenya

Ranitidine - Drug Details

Ranitidine (Zantac)

Classification
H2 Receptor Antagonist
Mechanism of Action
Indications
GERD, peptic ulcer disease
Dosage and Administration
150 mg twice daily or 300 mg once daily at bedtime
Forms
Tablet, syrup, injection
Side Effects
Headache, dizziness, constipation
Contraindications
Porphyria, severe renal impairment
Interactions
May alter the effects of drugs that require an acidic pH for absorption
Precautions
Use caution in elderly patients and those with renal impairment
Pharmacokinetics
Absorbed in the intestines, metabolized minimally, excreted in urine
Pharmacodynamics
Reduces stomach acid and relieves symptoms of GERD
Storage Requirements
Store at room temperature, away from moisture and light
Patient Counselling
Take at the same time each day, with or without food
Back to List
ClinicalMedHub - Modern Footer

ClinicalMedHub

Comprehensive medical resources, research tools, and professional networking for healthcare providers and patients worldwide.

Scroll down to see the modern footer design